placebonaut
Bluelighter
- Joined
- Feb 7, 2026
- Messages
- 1,576
I've ponder the same thing, I suspect is just as simple as demand, the market polarised around 2C-B, then not enough demand to bother making the other stuff, I think the synthesis isn't really a blocker.PREACH
FFS I WAS THIS CLOSE TO TRYING 2c-P BACK IN THE LATE 2000's! Haven't seen or heard of it since. Mate n my good friend, his gf, tried it at a festival and quote 'there's crocodile's in the clouds' - we were eating acid in order TO KEEP UP WITH THEIR VISUAL LEVEL but NEVER got there!
Now? Barely heard anyone even mention the regular 2c's range...
Never mind the 2c-T-X compounds, haven't been about in ages and I don't get why. Chemist knowledge lost? Precursor problem?
If chemists even did 'small batch' runs - they'd develop a bigger, albeit slightly niche at first, market ala 4-MMC(best example of society wide 'legal xtc-like chemical' in modern time) or MXE.
(hopefully once more of the younger modern masses in Bio-chem someday see P.H.I.K.A.L - they'll see a whole world to explore.)
I do wonder what the 'holding back' factor is, precursors? Good chemists? CBA? Thinks there's no interest? ARGH I've so many questions for these lads hahaha
the demand part is also driven by risk of taking the other 2C drugs - high doses of some of the others can lead to problems
